Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.31 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL596557 | 1.00 | CYP2C19 (0.33) | CYP2C19OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL9654521 | 0.97 | RYR2 (0.33) | CYP2C19OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL596917 | 0.97 | CYP2C19 (0.34) | CYP2C19OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL596112 | 0.91 | CYP2C19 (0.34) | CYP2C19USP2TSHRALDH1A1 | |
| SCHEMBL9435944 | 0.90 | CYP4F2 (0.44) | TSHRCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL5587309 | 0.90 | CYP4F2 (0.44) | TSHRCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL9324695 | 0.90 | CYP4F2 (0.44) | TSHRCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL10037414 | 0.90 | CYP4F2 (0.44) | TSHRCYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL25341042 | 0.88 | OPRM1 (0.45) | OPRM1OPRD1OPRK1OPRL1TSHR | |
| SCHEMBL7748710 | 0.88 | CPB2 (0.44) | TSHRCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8115043-B2 | Method for producing cyclic olefin compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-14 | — | — | US | disclosed |
| US-7786224-B2 | Liquid composition of alicyclic diepoxide, curing agent and/or curing accelerator | DAICEL CHEMICAL INDUSTRIES, LTD (JP) | 2010-08-31 | — | — | US | disclosed |
| US-7732627-B2 | High-purity cycloaliphatic diepoxy compound and preparation process thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20090062580-A1 | Method for Producing Cyclic Olefin Compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-2031006-A1 | Process for producing epoxy compound, epoxy resin composition and use thereof, ultraviolet-curable can coating composition, and process for producing coated metal can§ | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-03-04 | — | — | EP | disclosed |
| EP-2014634-A1 | PROCESS FOR PRODUCTION OF CYCLIC OLEFINS | Daicel Chemical Industries, Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1834949-A1 | HIGH-PURITY ALICYCLIC DIEPOXY COMPOUND AND PROCESS FOR PRODUCING THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2007-09-19 | — | — | EP | disclosed |
| US-20070179256-A1 | High-purity alicyclic epoxy compound, process for production of the same, curable epoxy resin composition, cured product thereof, and application thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| EP-1726588-A1 | HIGH-PURITY ALICYCLIC EPOXY COMPOUND, PROCESS FOR PRODUCING THE SAME, CURABLE EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, AND USE | Daicel Chemical Industries, Ltd. (JP) | 2006-11-29 | — | — | EP | disclosed |
| US-20040242839-A1 | Method of producing epoxy compound, epoxy resin composition and its applications, ultraviolet rays-curable can-coating composition and method of producing coated metal can | TAKAI HIDEYUKI (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1389615-A1 | PROCESS FOR PRODUCING EPOXY COMPOUND, EPOXY RESIN COMPOSITION AND USE THEREOF, ULTRAVIOLET-CURABLE CAN COATING COMPOSITION, AND PROCESS FOR PRODUCING COATED METAL CAN | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2004-02-18 | — | — | EP | disclosed |
| US-20030059618-A1 | Method of producing epoxy compound, epoxy resin composition and its applications, ultraviolet rays-curable can-coating composition and method of producing coated metal can | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DUOX2, SQLE, HPD | CYP2C19 450/4885OPRM1 917/4885OPRD1 225/4885 |
| US-20090062580-A1 | Method for Producing Cyclic Olefin Compound | ADH1C, ADH1A, DHCR24 | CYP2C19 1063/4885OPRM1 998/4885OPRD1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.